A pharmaceutical company for womxnThe term womxn includes all cis, trans and non-binary people.
Our Purpose
To provide safe, effective and innovative solutions to improve the well-being of womxnThe term womxn includes all cis, trans and non-binary people..
Our Vision
Thinking outside the box to cover health needs that were previously ignored.
What sets us apart
- Medical or societal, we listen to the needs of all womxnThe term womxn includes all cis, trans and non-binary people..
- We dare to implement innovative projects that are important to us.
- We propose safe and effective solutions that, while still non-existent, are completely essential.
- We make our products accessible and at a fair price for womxnThe term womxn includes all cis, trans and non-binary people. around the world..
Our Values
Togetherness - Diversity - Listening - Daring
Our Founder
MD, PhD André Ulmann is a renowned entrepreneur
in the field of womxnThe term womxn includes all cis, trans and non-binary people.’s health.
Having set up various pharmaceutical companies, he founded, in particular, HRA in 1996, which designed and
marketed the first “morning after pill”.
Always at the forefront of societal developments, André Ulmann founded CEMAG Care to meet the unmet medical needs of all womxnThe term womxn includes all cis, trans and non-binary people., regardless of the obstacles.
Our Pharmaceutical Company
We are a dynamic, motivated team! Our projects are important to us: we are the first users of our products.
Our everyday goal is to give womxnThe term womxn includes all cis, trans and non-binary people. control of their bodies at every stage of their lives.
What we do
MEDICAL
DEVICES
- Identifying clinical needs
- Developing MDs and IVDs
- Materiovigilance
- Identifying optimal distribution methods
PHARMACEUTICAL
OPERATIONS
- French pharmaceutical distributor
- Identifying clinical needs
- Development
- Regulatory activities (preparation and submission of regulatory files)
- Medical affairs (pharmacovigilance, materiovigilance, medical information, scientific committees, literature reviews, drafting files, etc.)
- Pharmacovigilance and business services for third parties
NGOS
- Facilitating links between the pharmaceutical industry and non-profit organisations (NGOs)
- Collaborating with NGOs on joint projects
- Donating medicines, medical devices and equipment
- Maintaining a network of close relationships with NGOs
Our commitments
RELATIONSHIPS OF TRANSPARENCY
CEMAG Care acts by respecting the rules of ethics and the principle of transparency of interests in application of the French Act of December 29, 2011 and the Decree of May 21, 2013. CEMAG Care publishes all granted advantages and remunerations in the frame of agreements signed with Healthcare professionals on the website of the French Ministry of Social Affairs and Health:
